Literature DB >> 6323638

Peripheral neuropathy induced by amiodarone chlorhydrate. A clinicopathological study.

J F Pellissier, J Pouget, D Cros, B De Victor, G Serratrice, M Toga.   

Abstract

Four cases of amiodarone neuropathy are reported. Patients presented a sensorimotor neuropathy with distal predominance. Improvement occurred after drug discontinuation. Nerve conduction velocities were significantly decreased. Other secondary effects of amiodarone were noted in two cases. In one case serum levels of amiodarone and N-monodesethylamiodarone were evaluated during and after treatment. Pathological study of nerve with morphometric evaluation was performed. Axonal degeneration changes were predominant in 3 cases. Aspects of segmental demyelination and remyelination were noted in one case and related to secondary demyelination. Numerous lysosomal inclusions were present in Schwann cells, fibroblasts, capillary endothelial and perithelial cells and in perineural cells. Similar inclusions have been observed in other drug-induced lipidosis. The factors responsible for this neuropathy are unknown. In one case, amiodarone-induced hepatic failure might explain the persisting high serum levels of the drug.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6323638     DOI: 10.1016/0022-510x(84)90200-4

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  9 in total

1.  The effects of plasmapheresis on thyroid hormone and plasma drug concentrations in amiodarone-induced thyrotoxicosis.

Authors:  B Uzzan; E Pussard; A Leon; D Bekhechi; A Krivitzky; E Modigliani; G Perret; R Vassy; A Berdeaux; J F Giudicelli
Journal:  Br J Clin Pharmacol       Date:  1991-03       Impact factor: 4.335

2.  Unusual amiodarone toxicity in a child.

Authors:  Bahram Kakavand; Thomas G Di Sessa
Journal:  J Pediatr Pharmacol Ther       Date:  2008-04

3.  Traumatic fascicular neuroma.

Authors:  H H Goebel; R Besser
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

4.  Peripheral neuropathy during longterm high-dose amiodarone therapy.

Authors:  A G Fraser; I N McQueen; A H Watt; M R Stephens
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-06       Impact factor: 10.154

5.  Peripheral neuropathies during treatment with almitrine: report of 46 cases.

Authors:  P Bouche; L Lacomblez; J M Leger; M P Chaunu; H Ratinahirana; P Brunet; J J Hauw; H P Cathala; D Laplane
Journal:  J Neurol       Date:  1989-01       Impact factor: 4.849

Review 6.  The clinical spectrum of amiodarone-associated optic neuropathy.

Authors:  Lenworth N Johnson; Gregory B Krohel; Eric R Thomas
Journal:  J Natl Med Assoc       Date:  2004-11       Impact factor: 1.798

7.  Antiarrhythmic drugs and polyneuropathy. The Collaborative Group for the Study of Polyneuropathy.

Authors: 
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-03       Impact factor: 10.154

8.  Amiodarone and desethylamiodarone increase intrasynaptosomal free calcium through receptor mediated channel.

Authors:  P R Kodavanti; S N Pentyala; P R Yallapragada; D Desaiah
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-02       Impact factor: 3.000

9.  Amiodarone-induced hepatitis and polyneuropathy.

Authors:  Hyun Mo Kang; Yoon Sae Kang; Seok Hyun Kim; Jae Kyu Seong; Dae Young Kang; Heon Young Lee; Byung Seok Lee
Journal:  Korean J Intern Med       Date:  2007-09       Impact factor: 2.884

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.